Biopharmaceutical reports

FemTech Supports Women in the Workforce

While the term FemTech may be unfamiliar to some, there is wide and growing recognition among self-insured employers that are joining the...

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on life at its most...

Tech-First Companies Take the Lead in AI Drug Discovery

In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire...

Companies Making Automated Drug Discovery A Reality

Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a...

Artificial Intelligence in Drug Discovery and Biotech; 2022 Recap and Key Trends

The advent of AI in drug discovery at a glance The current advent of artificial intelligence (AI) is shaping the evolution of entire...

17 Companies Building the Future of Drug Development on a Chip

In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate...

Innovative Value-Based Price Programs Back in the Spotlight

Value-based plans are emerging as particularly attractive coverage options for therapies that become available after an FDA accelerated...

Upper Middle-Income Countries Left Out by New Merck/Ridgeback COVID-19 Antiviral Licensing Deal

As Merck (NYSE:MRK) and Ridgeback Biotherapeutics sign on to a licensing deal to expand global use of their COVID-19 capsule...

Medicare's National Coverage Determination Could Boost Chances of Limited Aduhelm Coverage

By opening a National Coverage Determination (NCD) on Biogen’s (NASDAQ:BIIB) Aduhelm (aducanumab) for Alzheimer’s disease, Medicare has...

Pepaxto's US Uptake to Stall in Multiple Myeloma Until FBA Provides Advice to Address Death Risk

Blood cancer oncologists are likely to hold back for now on using Oncopeptides’ (STO:ONCO) Pepaxto (melphalan flufenamide) in...

Subscribe to Our Journal